Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $505.87 | 23 | 97.3% |
| Education | $13.89 | 1 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $54.02 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $53.61 | 3 | $0 (2023) |
| Tactile Systems Technology Inc | $48.24 | 2 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $42.85 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $32.39 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $30.78 | 2 | $0 (2024) |
| Inspire Medical Systems, Inc. | $30.67 | 1 | $0 (2024) |
| Pinnacle Biologics, Inc | $27.79 | 1 | $0 (2024) |
| Grifols USA, LLC | $24.93 | 1 | $0 (2024) |
| BeiGene USA, Inc. | $24.77 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $265.48 | 11 | REVANCE THERAPEUTICS, INC. ($42.85) |
| 2023 | $33.41 | 2 | AstraZeneca Pharmaceuticals LP ($19.41) |
| 2022 | $14.67 | 1 | Genentech USA, Inc. ($14.67) |
| 2020 | $35.75 | 2 | Allergan, Inc. ($22.61) |
| 2019 | $15.82 | 1 | AstraZeneca Pharmaceuticals LP ($15.82) |
| 2018 | $49.49 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18.50) |
| 2017 | $105.14 | 4 | Amgen Inc. ($54.02) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Pulmonology | ||||||
| 09/25/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $42.85 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 09/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: NEUROLOGY | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: RESPIRATORY | ||||||
| 05/24/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Oncology | ||||||
| 05/01/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 02/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2024 | Pinnacle Biologics, Inc | Photofrin (Drug) | Food and Beverage | Cash or cash equivalent | $27.79 | General |
| Category: Oncology | ||||||
| 01/29/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Airway Clearance Device | ||||||
| 01/17/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: HFCWO | ||||||
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Respiratory | ||||||
| 10/10/2023 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 03/17/2022 | Genentech USA, Inc. | GAZYVA (Biological), POLIVY | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: BioOncology | ||||||
| 02/28/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/11/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Respiratory | ||||||
| 10/21/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.82 | General |
| 11/30/2018 | AstraZeneca Pharmaceuticals LP | TUDORZA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Respiratory | ||||||
| 11/16/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2018 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Oncology | ||||||
| 11/07/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: RESPIRATORY | ||||||
| 04/14/2017 | Arrow International, Inc. | CVC - Arrow (Device) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Vascular Access | ||||||
| 03/29/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: RESPIRATORY | ||||||
| 02/23/2017 | Amgen Inc. | Blincyto (Biological) | Food and Beverage | In-kind items and services | $54.02 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 486 | 1,024 | $433,827 | $90,103 |
| 2022 | 7 | 610 | 1,565 | $773,848 | $143,206 |
| 2021 | 6 | 619 | 1,539 | $768,123 | $147,222 |
| 2020 | 10 | 406 | 711 | $399,400 | $67,518 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 159 | 364 | $149,027 | $33,091 | 22.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 154 | 458 | $130,214 | $27,676 | 21.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 68 | 93 | $86,091 | $15,113 | 17.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 80 | $54,618 | $10,536 | 19.3% |
| G0508 | Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth | Office | 2023 | 14 | 14 | $7,350 | $2,202 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 15 | $6,527 | $1,485 | 22.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 288 | 1,113 | $470,718 | $87,343 | 18.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 135 | 215 | $196,629 | $35,914 | 18.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 91 | 93 | $75,958 | $14,113 | 18.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 100 | $29,176 | $5,481 | 18.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 15 | 15 | $510.00 | $140.65 | 27.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 17 | 17 | $425.00 | $118.05 | 27.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 12 | 12 | $432.00 | $96.16 | 22.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 303 | 1,055 | $445,325 | $85,056 | 19.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 112 | 194 | $180,150 | $33,066 | 18.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 119 | 121 | $99,099 | $20,727 | 20.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 63 | 147 | $42,900 | $8,190 | 19.1% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2021 | 11 | 11 | $374.00 | $105.05 | 28.1% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 11 | 11 | $275.00 | $77.66 | 28.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 100 | 161 | $192,573 | $28,579 | 14.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 103 | 236 | $104,212 | $19,591 | 18.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 57 | 166 | $48,815 | $9,556 | 19.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 29 | 29 | $24,443 | $5,118 | 20.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 15 | 15 | $10,587 | $1,546 | 14.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 17 | 18 | $4,142 | $1,126 | 27.2% |
About Dr. Muhammad Raza, M.D
Dr. Muhammad Raza, M.D is a Internal Medicine healthcare provider based in Allen, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881661593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Raza, M.D has received a total of $519.76 in payments from pharmaceutical and medical device companies, with $265.48 received in 2024. These payments were reported across 24 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($505.87).
As a Medicare-enrolled provider, Raza has provided services to 2,121 Medicare beneficiaries, totaling 4,839 services with total Medicare billing of $448,049. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Allen, TX
- Active Since 03/01/2006
- Last Updated 02/14/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1881661593
Products in Payments
- Blincyto (Biological) $54.02
- Flexitouch Plus (Device) $48.24
- DAXXIFY (Drug) $42.85
- TRELEGY ELLIPTA (Drug) $30.78
- INSPIRE (Device) $30.67
- Photofrin (Drug) $27.79
- Prolastin-C Liquid (Biological) $24.93
- BRUKINSA (Drug) $24.77
- TEFLARO (Drug) $22.61
- IBRANCE (Drug) $19.68
- TEZSPIRE (Biological) $19.41
- CVC - Arrow (Device) $19.25
- SPIRIVA RESPIMAT (Drug) $18.50
- TUDORZA (Drug) $18.38
- UTIBRON (Drug) $17.98
- SMARTVEST (Device) $16.25
- GAZYVA (Biological) $14.67
- STIOLTO (Drug) $13.89
- Hillrom - Vest System Model 105 Home Care (Device) $13.52
- Arikayce (Drug) $13.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Allen
Sameera Tallapureddy, Md, MD
Internal Medicine — Payments: $91,942
Luke Ouyang, Md, MD
Internal Medicine — Payments: $11,346
Dr. Anthony Nebor, M.d, M.D
Internal Medicine — Payments: $10,652
Rihab Kheir, Md, MD
Internal Medicine — Payments: $7,289
Satish Bagdure, M.d, M.D
Internal Medicine — Payments: $5,312
Dr. Saira Samani, M.d, M.D
Internal Medicine — Payments: $4,684